Add text here
Add text here
|Infectious Disease Testing Laboratories, Performing COVID-19 Tests|
|Advanced Laboratory Testing||Testing||Ireland||Assisting government laboratories with their COVID-19 testing.|
|Africa Health Research Institute||Testing||South Africa||Performing COVID-19 surveillance studies.|
|CAPRISA||Testing||South Africa||Performing COVID-19 surveillance studies.|
|Enfer Medical Group||Testing||Ireland||Performing COVID-19 Testing|
|Excalibur Healthcare||Testing||UK||Providing COViD-19 testing to UK public and private organizations|
|hVIVO||Testing||UK||hVIVO COVID Clear Test is the most accurate antibody test available to employers in the UK and Ireland, helping them to get their people back to work.|
|Instituto Butantan||Testing & Vaccine||Brazil||Instituto Butantan supplies the Brazilian public health system with 90% of the antivenin and 65% of all vaccines distributed in the country. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, 100 million are produced by Butantan. In particular, Instituto Butantan manufactures 100% of the influenza vaccine doses used by the Ministry of Health. Presently, we are the largest flu vaccine manufacturer in the Southern Hemisphere. Butantan is already processing COVID samples and is going to coordinate a network of 38 Laboratories in the Sao Paulo area.|
|Imanis Life Sciences||Testing||USA||IMMUNO-COV
A NEUTRALIZING ANTIBODY TEST
The Test for Antibodies that Block Infection
Receive the deepest level of understanding of the body’s defense status.
The IMMUNO-COV™ neutralizing antibody test is a functional assay that quantifies the virus-neutralizing function of antibodies that can stop SARS-CoV-2, the virus that causes COVID-19.
|Los Alamos National Laboratory||Testing||USA||Los Alamos is focusing its scientific and technical capabilities in response to COVID-19 in several key areas: modeling, laboratory testing options, manufacturing, application of AI and machine learning, medical countermeasures, and high-performance computing.
|MDNA||Testing||UK||Providing COViD-19 testing to UK public and private organizations|
|National Public Health Laboratory Services (NPHLS) Kenya||Testing||Kenya|
|NIH NIAID||Testing||USA||NIH has made incredible progress toward understanding, diagnosing, treating, and preventing SARS-CoV-2 infection and COVID-19 in the past year. However, new challenges have come to light as the pandemic has evolved, necessitating a corresponding evolution in the NIH response, which is reflected in this NIH-Wide Strategic Plan for COVID-19 Research (hereafter referred to as the “Strategic Plan”). This second iteration of the Strategic Plan includes updates throughout the document to convey the progress made, new research studies planned, and NIH community outreach efforts. The most significant updates to the Strategic Plan are highlighted below:
• Investigating and treating the long-term health consequences of COVID-19, including Post-Acute Sequelae of SARS-CoV-2 Infection (PASC; also referred to as Long COVID) and pandemic-related impacts on the overall physical and mental health of Americans
• Understanding and responding to new SARS-CoV-2 variants that contain mutations in the spike protein of the virus that may impact the effectiveness of treatments and vaccines against SARS-CoV-2
• Highlighting progress on the development of diagnostic tests, vaccines, and treatments for SARS-CoV-2 infection and developing implementation strategies to determine efficient, effective methods of providing these resources
|Ortho Clinical Diagnostics||Testing||USA||Meeting the demands of the pandemic with reliable, high-throughput testing solutions for both SARS-CoV-2 infection and antibody detection. Ortho’s integrated VITROS® system allows labs to concurrently run routine and COVID-19 tests, confidently delivering trusted results.
THE VITROS® SARS-COV-2 ANTIGEN TEST
Ortho’s Antigen Test is a high-throughput, highly accurate test that detects acute infection of SARS-CoV-2.
THE VITROS® COVID-19 TOTAL AND IgG ANTIBODY TEST
Ortho’s Antibody Test detects antibodies to the S1 protein, a primary target for neutralizing antibodies against SARS-CoV-2.
ENHANCED BY THE VITROS® PERFORMANCE DASHBOARD
View productivity data from Ortho analyzers including test volumes, positivity rates, quality, and efficiency information to help you make more informed decisions for your hospital and community.
|Province of Manitoba, Cadham Provincial Laboratory||Testing||Canada||https://www.gov.mb.ca/health/publichealth/cpl/index.html|
|PT Genomik Solidaritas Indonesia||Testing||Indonesia||www.gsilab.id
|PT Kartika Bina Medikatama (Medika Plaza)||Testing||Indonesia||www.medikaplaza.com
|Province of Ontario, Public Health Ontario Laboratory Services||Testing||Canada||Public Health Ontario provides scientific and technical advice to the Ministry of Health, local public health units, and other health system partners to support COVID-19 response efforts. This includes:
- conducting laboratory testing and providing advice on evolving testing technologies and approaches
- surveillance of cases and epidemiological data analysis and reporting
- providing advice to support developing public health guidance, decision-making, and program, and service delivery
- generating reports summarizing scientific evidence and best practices
- infection prevention and control training, guidance and support
- outbreak management advice and support
- contact tracing training and implementation of various supports to local public health units
- scientific and technical advice, resources and surveillance to support the implementation of COVID-19 vaccine programs
|Province of Saskatchewan, Roy Romanow Provincial Laboratory (RRPL)||Testing||Canada||https://www.saskhealthauthority.ca/Services-Locations/RRPL
|Public Health Agency of Canada – National Microbiology Laboratory||Testing||Canada||The National Microbiology Laboratory (NML) provides critical scientific leadership for Canada’s response to COVID-19.
- supports diagnostic testing across Canada
- conducts research on COVID-19
- creates models and manages data gathering to help guide public health planning and predict the course of the outbreak
|Randox||Testing||UK||Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of Coronavirus. Is also providing COVID-19 testing support for the UK Government|
|Remote Medical International||Testing||UK||Providing mobile testing service to UK DHSC (Dept Social Health Care)|
|Royal College of Pathologist of Australasia Quality Assurance Program||Testing||Australia||In response to requests from laboratories and from the Australian Government’s Department of Health, and in line with the Enhancing Laboratory Capacity and Capability contract RCPAQAP has with the Department of Health, RCPAQAP Biosecurity will be offering a proficiency testing program (PTP) for the 2019-novel coronavirus, SARS-CoV-2. This will assist with the response to the outbreak of COVID-19, a respiratory illness caused by a novel coronavirus first identified in Wuhan, Hubei Province and recently declared a Public Health Emergency of International Concern by the WHO.
RCPAQAP Biosecurity has organized for two rounds of a PHLN Module: SARS-CoV-2 and other coronaviruses. Round 1 was offered to a select number of laboratories however, Round 2 is to be offered to both public and private Australian laboratories free of charge in this instance, with the support of the Department of Health, in recognition of the extraordinary circumstances of the SARS-CoV-2 outbreak.
|Scottish Environment Protection Agency (SEPA)||Testing||UK||At the Scottish Environment Protection Agency (SEPA) we are working with our partner agencies to sample sewage influents for analysis in our Microbiology/Genomics lab for the presence of COVID-19 RNA. This data will be used to assist in tracking the geographical spread of the virus in Scotland.
LabWare is at the core of this work and is being used to plan and schedule the sampling activities, streamline the laboratory working processes, collect result data and provide reporting data sets for our GIS-based reporting tools.
|Siemens Healthcare Diagnostics||Testing||USA|| At Siemens Healthineers, we are aware of the urgency and complexity of the current situation, and we are working hard to provide the best possible support to healthcare providers at each stage of COVID-19 patient care: diagnosis, prognosis, therapy, and follow-up.
We offer a broad portfolio of technology solutions to support you along the patient pathway. And in our “New Normal” Insights Series papers, we explore offer ideas, analysis, and practical advice on how to combat the pandemic, emerge stronger from the crisis and be better prepared for future challenges
|South African Medical Research Council HIV Prevention Research Unit (HPRU)||Testing||South Africa||Performing COVID-19 surveillance studies.|
|State of Delaware, Public Health Laboratory||Testing||USA||https://dhss.delaware.gov/dph/lab/labs.html
|State of Florida, Bureau of Public Health||Testing||USA||Laboratory Requisition: For FDOH testing events, electronic test orders are required using Mobile LabWare tablets. CHD clinics/collections must also use Mobile LabWare or HMS to create an electronic order. If electronic ordering capability is not possible, complete and includes in the package FDOH Form DH1847. Please note that electronic ordering enables BPHL to process the test and report the result in a timelier manner.
|Texas Department Of State Health Services Public Health Laboratory||Testing||USA||The DSHS Austin Laboratory has been funded by the Centers for Disease Control and Prevention (CDC) to perform Next-Generation Sequencing of SARS-CoV-2 as part of the public health response to COVID-19 in Texas. The data we gather from sequencing can inform us about how the virus is spreading in our communities, where it originated, how it may be changing over time in different geographical locations, and whether these changes may affect diagnostic testing, public health response measures, or vaccine development.
The DSHS Laboratory is now accepting specimens from healthcare providers and COVID-19 testing laboratories statewide to increase its sequencing efforts as new genetic variants of SARS-CoV-2 have been reported within the State of Texas. DSHS is very interested in receiving specimens from patients who have been re-infected with COVID-19 and those suspected of having a genetic variant of concern.
|State of New Mexico, Scientific Laboratory Division||Testing||USA||https://www.nmhealth.org/about/sld/
|Utah Public Health Laboratory||Testing||USA||Free Covid-19 Testing and Same Day Results
Utah Public Health Laboratory, 4431 South 2700 West, Taylorsville, (drive-through in the west parking lot) starting on Wednesday, March 17th, Monday – Friday, 7 a.m. to 11 a.m. Register here.
This testing is sponsored by the Utah Department of Health offering both saliva PCR and swab PCR testing with same-day results. Individuals electing to complete saliva testing will need to avoid eating, drinking, smoking, or chewing gum 30 minutes prior to the collection.
|State of Oklahoma, Public Health Laboratory||Testing||USA||https://oklahoma.gov/health/prevention-and-preparedness/public-health-laboratory.html
|South Dakota State Public Health Laboratory||Testing||USA|
|The Discovery Health lab||Testing||USA||https://thediscoverylabs.com/
|Pharmaceutical Companies Developing a COVID-19 Vaccine or Treatment|
|APB Association Pharmacy||Treatment||Belgium||Branch organization for pharmacists. Takes care of informing pharmacists and answers questions from pharmacists about COVID-19.|
|Ardena Biochemical Laboratory BV||Treatment||Netherlands||In the worldwide battle against the Coronavirus, many clinical studies are being initiated to test the efficacy of Chloroquine and Hydroxychloroquine, two existing anti-malaria therapeutics. In support of this important and urgent global endeavor, our bioanalytical team has developed LC-MS/MS methods for the quantification of both compounds in human plasma.|
|AstraZeneca||Treatment||UK||A new clinical trial evaluating how one of our existing medicines might help alleviate the exaggerated immune response that can result in pneumonia, respiratory failure, and death of patients hospitalized with COVID-19 infections.
AstraZeneca is joining forces with government and academia with the aim of discovering novel Coronavirus neutralizing antibodies.
AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19.
|Bayer||Treatment||Germany||Product Resochin (originally used to fight against Malaria) in countries like China, Italy, and the USA - it contains Chloroquine, which has been found in some situations to be helpful for COVID infected patients to get healthy again.|
|BioNTech||Vaccine||Germany||Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening. Pfizer and BioNTech enter into a collaboration agreement to co-develop the potential COVID-19 vaccine. The company shares additional data and analysis of Azithromycin. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19-related pneumonia.
Donations: We have made available EUR 5.8 million for financial and in-kind donations for local emergency aid across the globe. We are also working with local organizations that use financial and medicine donations to organize help for patients in their communities.
|Boehringer Ingelheim Pharma GmbH & Co. KG||Treatment||UK||Research for COVID-19 therapies: Since January, we have freed up a growing team of currently more than 100 highly engaged scientists from all areas of research and development (R&D), to work on projects aimed at finding potential treatment solutions for COVID-19. As this work evolves, we will commit further experts from multiple disciplines, as well as increased lab capacity.|
|CSL Behring GmbH||Treatment||Germany||A pharmaceutical company with a focus on rare diseases. Member of the CoVIg-19 Plasma Alliance.|
|CSL Plasma||Treatment||Germany||A pharmaceutical company with a focus on human plasma. Member of the CoVIg-19 Plasma Alliance.|
|Cipla||Testing||India||Sets up an INR 25 crore ‘Caring for Life’ COVID-19 dedicated fund to support patients, the healthcare ecosystem, and communities. Includes contribution from employees towards this compassionate cause.
Launches a spate of relief efforts for advance testing, to safeguard healthcare providers and extend humanitarian care to communities with supplies of medicines, essential hygiene items, and food.
|Fresenius Kabi Deutschland GmbH||Treatment||Germany||One of the world's largest pharmaceutical companies. Fresenius Kabi takes comprehensive measures to increase the supply of essential drugs during the COVID-19 pandemic.|
|GBA PHARMA GmbH||Testing||Germany||GBA Group Pharma is one of Europe’s largest and most experienced service providers for the pharmaceutical and biotech sector.|
|Gilead||Treatment||USA||Gilead is focused on deploying our resources and decades of antiviral expertise to help patients and communities fighting the COVID-19 pandemic.
Since the outset of the pandemic, we have worked closely with global health authorities to respond through the appropriate use of Veklury® (remdesivir). Veklury is a nucleotide analog invented by Gilead, building on more than a decade of the company’s antiviral research. Veklury has broad-spectrum antiviral activity both in vitro and in vivo in animal models against multiple emerging viral pathogens, including Ebola, SARS, Marburg, MERS, and SARS-CoV-2, the virus that causes COVID-19.
Veklury has been approved or authorized for temporary use as a COVID-19 treatment in approximately 50 countries worldwide.
|GlaxoSmithKline||Vaccine||UK||Supporting research and production of candidate COVID-19 vaccines.
GSK has joined forces with Sanofi, bringing together two of the world’s largest vaccine companies in an unprecedented collaboration to fight COVID-19.
Collaborating with the University of Queensland, Clover Biopharmaceuticals, and Xiamen Innovax Biotech Co., Ltd. We believe that more than one vaccine will be needed and we’re hoping that there will be a number of successful vaccines developed with our pandemic adjuvant technology.
|HSE Public Health Services Executive - Ireland||Testing||Ireland||The Health Services Executive is responsible for the provision of health and personal social services for everyone living in Ireland. Has initiated and set up specific COVID-19 testing services.|
|Incyte||Treatment||USA||In March 2021, we announced results from the Phase 3 DEVENT study evaluating the efficacy and safety of ruxolitinib (5mg and 15mg) plus standard of care (SoC) versus SoC in patients with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS), a type of respiratory failure characterized by rapid onset of widespread inflammation in the lungs, with disease severity requiring mechanical ventilation. Improvement in mortality for each dose compared to placebo (primary endpoint), while trending toward positive, was not statistically significant for the overall study population. However, results showed significant improvement in mortality in U.S. study participants at both doses, and in the overall population when data from both treatment arms were pooled.
|Instituto Butantan - Brazil / Sao Paulo||Testing||Brazil||Instituto Butantan supplies the Brazilian public health system with 90% of the antivenin and 65% of all vaccines distributed in the country. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, 100 million are produced by Butantan. In particular, Instituto Butantan manufactures 100% of the influenza vaccine doses used by the Ministry of Health. Presently, we are the largest flu vaccine manufacturer in the Southern Hemisphere. Butantan is already processing COVID samples and is going to coordinate a network of 38 laboratories in the Sao Paulo area.|
|Janssen Vaccines (J&J)||Vaccine||Netherlands||Johnson & Johnson announces a lead vaccine candidate for COVID-19.
In January, Johnson & Johnson announced it would provide $250 million over 10 years to help inspire, recruit, train, retain and mobilize frontline health workers through its Johnson & Johnson Center for Health Worker Innovation.
In March, the company committed an additional $50 million earmarked specifically to support doctors, nurses, midwives, community health workers and others on the front lines fighting COVID-19.
Ethicon, a Johnson & Johnson medical devices company, and not-for-profit company, Prisma Health announced a collaboration in early April to manufacture and distribute a device developed by Prisma Health that allows a single ventilator to be fitted for use by two rescuable patients for ventilatory support during the COVID-19 pandemic until individual ventilators are available.
In response to the initial COVID-19 outbreak in China, Johnson & Johnson donated over $3.7 million in personal protective equipment (PPE) for frontline health workers, including goggles, protective suits, and masks.
|Oxford BioMedica||Treatment||UK||Cancer and Parkinson's treatment, working with Oxford's Jenner Institute to support the testing and potential production of COVID-19 vaccine.|
|Pfizer|| Our Path to Developing the Pfizer-BioNTech COVID-19 Vaccine
In the fight against COVID-19, a vaccine is a critical part of addressing the global health crisis by decreasing rates of infection, disease, and death worldwide. Pfizer and BioNTech leveraged decades of scientific expertise to design and execute a rigorous Phase 3 clinical trial program to make the Pfizer-BioNTech COVID-19 Vaccine available as quickly and safely as possible. Today, we are continuing to evaluate data from this landmark trial, while also initiating new trials in special populations, such as pregnant women and children under 12. We are also planning studies to assess the potential need for boosters or modified vaccines in the event that newly emerging variants evade protection provided by the existing vaccine.
|Quotient BioSciences||Vaccine||UK||Has announced a collaboration with CytoAgents Inc to accelerate the development of a lead COVID-19 drug candidate into human clinical trials.|
|Regeneron||Treatment||USA||The U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for REGEN-COV™ (casirivimab with imdevimab) for the treatment of mild-to-moderate COVID-19 in adults, as well as in pediatric patients (weighing at least 40 kg who are at least 12 years of age), with positive results of direct SARS-CoV-2 viral testing and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
|STADA Arzneimittel AG||Treatment||Germany||STADA is a leading manufacturer of high-quality pharmaceuticals with a focus on generics, including specialty pharmaceuticals and non-prescription consumer healthcare products.|
|Sanofi||Vaccine||France||The company is studying two of its existing medicines as potential treatments for COVID-19 and leveraging its expertise to develop a new vaccine.
Development of an over-the-counter, self-testing solution, in collaboration with the Californian startup, Luminostics. Sanofi’s goal is to provide a smartphone-based solution that can be carried out at home without a healthcare professional or laboratory tests, lowering the risk of catching the virus for all involved.
Sanofi is supporting clinical trials to determine whether two of its medicines can help patients with COVID-19. One option is currently being tested to evaluate its impact on symptoms in patients with severe COVID-19 in Italy, Spain, Germany, France, Canada, and Russia, with a second trial led by Regeneron for patients in the US.
|TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH||Vaccine||Germany||University spin-off. Innovative immunological research institute. TRON was asked by a renowned industrial partner to support the development of a vaccine against the currently pandemic Coronavirus with preclinical studies.|
|Takara Bio||Treatment||Japan||The Chinese Center for Disease Control and Prevention recommended Takara Bio's One Step PrimeScript RT-PCR Kit (Perfect Real Time) for the detection of the novel Coronavirus.|
|Valneva||Vaccine||UK||In September 2020, Valneva announced a collaboration with the UK government, which has the option to purchase up to 190 million doses through 2025. So far, the UK Government has ordered 100 million doses to be delivered in 2021 and 2022 and retains options over a further 90 million doses for supply between 2023 and 2025. The UK government is also investing up-front in the scale-up and development of the vaccine candidate.|
|Teva||Treatment||Israel||Donated treatment. Recently this effort included enabling tablets and API manufactured in our Goa, India plant to be retrieved in a timely way so as to be able to expand access to the medicine globally.|
|Viroclinics Biosciences BV||Treatment||Netherlands||International partnership progresses UQ COVID-19 project.|
|Other Public Health Laboratories|
|ARPA Veneto||Testing||Italy||The laboratory performs testing on food and drinking water for the Ministry of Health.|
|Aahus University, Department of Forensic Medicine||Testing||Denmark||Analyzing Forensic Chemistry samples, Aarhus, Denmark.|
|AsureQuality Limited||Testing||New Zealand||AsureQuality provides food assurance and biosecurity services to the food and primary production sectors worldwide. Wholly owned by the New Zealand Government, AsureQuality has built a solid reputation for delivering expert services and value to the entire food supply chain. Every day their team of 1800 experts, based at locations throughout Australasia and Southeast Asia, work alongside customers in over 40 countries worldwide, to assure the safety and quality of food being produced for millions of people.|
|Biobank West||Biobank||Sweden||Collaboration between Region Västra Götaland and Sahlgrenska Academy at the University of Gothenburg, collecting, storing, and managing regional biobank samples - currently prioritizing studies related to COVID-19.|
|Biocon Limited||India||Biocon is responding to the COVID-19 outbreak, consistent with its belief that the pharmaceutical industry has a humanitarian responsibility to serve patients who are in need. Our people across various functions are committed to ensuring the continuity of the production and supply of our life-saving medicines and we are committed to ensuring their personal health and safety.|
|Burundi Ministry of Health||Testing||Burundi|
|CAIB||Testing||Spain||Public Health Laboratory Services.|
|CNTA||Testing||Spain||National food testing organization.|
|CityU Veterinary Diagnostic Laboratory Company Limited||Testing||Hong Kong||The mission of the CityU Veterinary Diagnostic Laboratory (CityU VDL) is to provide a comprehensive veterinary diagnostic service to the veterinarians and researchers of Hong Kong. The CityU VDL is also in a unique position to offer support for animal disease research.|
|Copenhagen University, Department of Forensic Medicine||Testing||Denmark||Analyzing Forensic Genetics samples. Copenhagen, Denmark.|
|DNAlysis Biotechnology||Testing||South Africa|
|Dr Reddy's Laboratories||Treatment||India||Engaged in various initiatives to contain and cope with the global spread of COVID-19:
Employee safety and well-being - taking necessary measures to secure the safety and well-being of our more than 22,000 employees across the globe.
The continued supply of medicines - Dr. Reddy’s remains steadfast in its commitment to ensuring that our patients and customers have access to affordable medicines.
Donations to COVID-19 support programs - monetary donations to the Government of Telangana to enable access to N95 masks for frontline health workers in the state; contribution to the Andhra Pradesh CM Relief Fund; in collaboration with Akshay Patra, we are now sponsoring 25,000 meals a day for those facing financial hardships; donating dry provisions to 20,000 families in need across Telangana and Andhra Pradesh; donate protective equipment, sanitizers and medicines to medical professionals, public servants and healthcare institutions; and, in the US, supplies of Dr. Reddy’s Hydroxychloroquine and Propofol are being provided directly to hospitals hit hard by the pandemic including in New York and New Jersey.
Production of sanitizers - in areas like Shreveport, Louisiana, in the US, our manufacturing facilities are using the excess capacity to produce hand sanitizers. These products are being donated to area hospitals and health systems in need.
Employee volunteering and contributions - employees have made personal monetary contributions to the Prime Minister’s CARES Fund in India and other relief funds. As an organization, Dr. Reddy’s has committed to support employee contributions through Dr. Reddy’s matching programs.
|Defence Reference Laboratory||Testing||Nigeria|
|Deutsches Rotes Kreutz - Blutspendedienst West||Biobank||Germany||German Red Cross - blood bank and blood testing facility for Western Germany.|
|East of Scotland Regional Health Authority||Testing||UK||Provides genetics screening service for the Grampian region. Providing COVID-19 testing support within the Tayside region.|
|East of Scotland Regional Hospital||Testing||UK||Provides genetics screening service for the Grampion region. Providing COVID-19 testing support within the Tayside region.|
|Eufets GmbH||Pharmaceutical||Germany||Contract development and manufacturing organization specialized in the industrialization of cell and gene therapy products such as viral vectors, cellular products, and in vitro transcribed mRNA.|
|Forensic Science South Australia / South Australia Police||Testing||Australia||Government forensic testing for the State of South Australia, Australia.|
|Genomed||Biobank||Portugal||Molecular medicine diagnostics.|
|Grünenthal GmbH||Pharmaceutical||Germany||A privately held pharmaceutical company, a global leader in pain management and related diseases.|
|HIV Pathogenesis Programme (HPP); Nelson R. Mandela School of Medicine||Testing||South Africa|
|Health Canada – Biologic and Radiopharmaceutical Drugs Directorate||Testing||Canada||Health Canada's Biologic and Radiopharmaceutical Drugs Directorate (BRDD) regulates biological drugs (products made from living sources, including vaccines), radiopharmaceuticals (drugs that have radioactivity), and cells, tissues, and organs for human use in Canada. The Directorate is also the regulatory authority responsible for the Assisted Human Reproduction (AHR) Act and its supporting regulations.
|Health Canada – Health Products and Food Branch||Testing||Canada||As the national regulator for health products, Health Canada plays an important role in Canada's response to the COVID-19 pandemic.
Our regulatory measures and guidance have allowed companies to put vital products such as personal protective equipment, testing devices, and hand sanitizers into the hands of Canada's health care workers and the Canadian public quickly. They help expedite clinical trials that support the rapid development of potential COVID-19 treatments and vaccines. The exceptional importation of drugs and medical devices that Canadians rely on for their health has also helped to prevent and ease shortages.
The health products sector and Canada's business community mobilized quickly. Health Canada collaborated with federal partners and international counterparts. Due to these collective efforts, we approved thousands of products. These products support areas of greatest need and include more than:
3,200 hand sanitizers and 149 hard-surface disinfectants 262 medical devices for patient safety and care, such as personal protective equipment, ventilators, and decontamination devices
26 testing devices for diagnosing COVID-19 and detecting the antibodies produced in response to a COVID infection 40 clinical trials, including the first clinical trial in Canada for a COVID-19 vaccine
|Hologic||Testing||UK||Are providing SAR-CoV-2 assay using the industry-leading installed base of Hologic's Panther instrument.|
|ICA - Colombia / National||Testing||Colombia|
|INC - Colombia / Bogota - Cancer Institute of Cancerology||Biobank||Colombia|
|Institute de Medicina Molecular||Biobank||Portugal|
|KI Biobank||Biobank||Sweden||The biobank provides services for the collection, handling, storage, and traceability of biobank samples both within and outside of Karolinska Institutet.|
|Karolinska University Hospital||Testing||Sweden||The hospital lab uses LabWare for newborn screening analyses and for doping testing.|
|Kenya Ministry of Health – AMREF||Testing||Kenya|
|LGC Group||CRO||UK||LGC’s Immunogenicity Centre of Excellence has successfully developed a COVID-19 antibody assay suitable for serum and dried blood sampling.
LGC’s assay can analyze up to 40,000 samples per day using serum or capillary blood collected remotely with Neoteryx’s Mitra® microsampling device, which is ideal for back-to-work testing as it can be performed away from a clinic or hospital environment and simply posted via regular mail to the LGC labs for analysis.
The assay for SARS-CoV-2 antibody testing achieves specificity of (95% CI) 100% (97.8-100.0) and sensitivity of (95% CI) 98.0% (87.0-99.0) for samples taken 21 days post positive PCR test.
LGC’s configured LabWare LIMS system is being used to manage the sample receipt and all aspects of plate management including the determination of outcomes, instrument interfacing, and reporting as well as disposal.
For more information visit lgcgroup.com/dds
|LKF-Laboratorium für Klinische Forschung GmbH||Pharmaceutical||Germany||Member of the GBA group focused on clinical trials. Specialized medical laboratory unit dedicated exclusively to supporting clinical trials of phases I – IV.|
|Lanagro - Brazil / National||Testing||Brazil|
|Livestock Improvement Corporation||Testing||New Zealand||New Zealand multinational farmer-owned co-operative which, for more than 100 years, has provided genetics expertise, information and technology to the dairy sector, aimed at improving the prosperity and productivity of farmers.|
|Lund University||Testing||Sweden||Sequencing and NGS facility at the Division of Oncology and Pathology.|
|Lupin Limited||Treatment||India||Set up a centralized ‘COVID-19 Taskforce’ to monitor the situation daily and put in place adequate safeguards to ensure the health and safety of our employees, develop a business continuity plan, and support the communities we operate in.
All our factories have been maximizing the production of life-saving drugs to ensure that despite the ongoing crisis, our drugs remain available for our communities around the world. We have ramped up production of Hydroxychloroquine Sulphate and Azithromycin – two drugs being explored as a potential treatment for COVID-19.
Our team at Lupin Human Welfare and Research Foundation is dedicating efforts towards the production of face masks for personnel involved in essential services; packed meals are also being served in Madhya Pradesh and Rajasthan to migrant workers who have been worst hit in this crisis.
|Marsabit Referral Hospital||Testing||Kenya|
|Medical Research Council||Testing||Uganda|
|Ministry of Agriculture||Testing||Brazil||The General Coordination of Agricultural Laboratories - CGAL - is the body of the Ministry of Agriculture, Livestock and Supply - MAPA - competent to manage and organize the laboratory activities of the Secretariat of Agricultural Defense. Together with the six national agricultural laboratories - Lanagros, CGAL constitutes the LANAGRO NETWORK. The work performed by this network plays a fundamental role in the control and supervision of food, beverages and agricultural inputs produced in Brazil and marketed in the country and abroad. It also has strategic action in the sanitary monitoring of herds and crops, participating in the guarantee of the sanitary status of the country and the control and sanitation of animal diseases and plant pests. MAPA will provide installed capacity, infrastructure, and technical teams from their laboratories to assist in Coronavirus testing analysis.|
|Ministry of Health (APHL)||Testing||Kenya|
|Ministry of Health - East Africa Public Health Laboratory Network (EAPHLN)||Testing||Kenya|
|Moi Teaching & Referral Hospital||Testing||Kenya|
|NSW Office of Environment & Heritage||Testing||Australia||Government soil and water testing.|
|National Center for Global Health and Medicine||Testing||Japan||A nationally owned research organization that pursues both experimental and transitional research for infectious diseases and others, contributing to global health and medicine.|
|National Institute for Environmental Studies||Testing||Japan||A nationally owned research organization that researches global environmental issues, environmental risks such as chemical substances, environmental issues in developing countries, etc., and monitors/observes elucidation and countermeasures of environmental problems.|
|New Zealand Ministry for Primary Industries||Testing||New Zealand||NZMPI is the public service department of New Zealand charged with overseeing, managing, and regulating the farming, fishing, food, animal welfare, biosecurity, and forestry sectors of New Zealand's primary industries.|
|North of Scotland Regional Hospital - Genetics Service||Testing||Scotland||Provides genetics screening service for the Grampion region.|
|Northern Territory Department of Primary Industry and Fisheries||Testing||Australia||Government testing in agriculture, biosecurity, fisheries, earth resources, energy, and forestry policy and programs in the Northern Territory, Australia.|
|NSF||Contract Lab||USA||Since the onset of COVID-19, organizations around the world have been faced with challenges in workplace safety. Scientific understanding is constantly evolving, and each week brings a better understanding of:
How to prevent transmission
New health data around real-time community spread
Successful efforts to contain the virus
In response to the COVID-19 pandemic, we’ve established a new service for state governments: COVID-19 compliance assessment with educational outreach and consulting services. We visit and assess local businesses for compliance with COVID-19 guidelines and provide detailed guidance and recommendations to businesses that may fall short of the requirements.
We often work with state governments, public health departments, and federal agencies to augment and expand their staffs while providing services and technical expertise aimed at protecting human health.
|Odense University, Department of Forensic Medicine||Testing||Denmark||Analyzing forensic medicine samples. Odense, Denmark.|
|PathWest Laboratory Medicine WA||Testing||Australia||Government food and water testing laboratories.|
|Pirbright Institute||Research||UK||Research infectious diseases in farm animals are not directly involved with COVID-19 testing as yet.|
|Public Health Agency of Canada – Laboratory for Foodborne Zoonoses||Testing||Canada||The Laboratory for Foodborne Zoonoses is one of the Public Health Laboratories at the Public Health Agency of Canada. It focuses on preventing infectious and chronic diseases by looking at public health risks that come from the interactions between animals, humans and the environment – also known as the 'One Health' approach. The lab works with provincial, federal and international public health partners to address priority public health risks in an integrated and proactive manner.
|Queensland Racing Science Center||Testing||Australia||Government testing for horse and greyhound racing industry.|
|Region Zealand||Biobank||Denmark||Collection and storage of biological material - have also a new specific workflow for receiving coronavirus samples in their regional LabWare Biobank. Two sites (Næstved and Roskilde), Denmark.|
|Rwanda National Reference Laboratory||Testing||Rwanda|
|Shanghai Institute of Food and Drug Control||Testing||China||Government testing in food and drugs.|
|Singapore Health Sciences Authority||Testing||Singapore||Government laboratories covering Forensic Chemistry and Physic Laboratory (Crime Unit, Documentation Unit), Illicit Drug Laboratory, Analytical Toxicology Laboratory (Drug Abuse Testing Unit, Clinical and Forensic Toxicology Unit), DNA Profiling Laboratory, Pharmaceutical Laboratory, Cosmetics Laboratory, Cigarette Testing Laboratory, Food Safety Laboratory (Food Testing Unit, Water Testing Unit).|
|Singapore Ministry of Home Affairs||Testing||Singapore||Government forensic testing.|
|Singapore Police Force||Testing||Singapore||Government forensic testing.|
|South African Medical Research Council – Genomics Centre||Testing||South Africa|
|South African Medical Research Council HIV Prevention Research Unit (HPRU)||Testing||South Africa|
|South African Tuberculosis Vaccine Initiative (SATVI)||Testing||South Africa|
|South-Eastern Norway Regional Health Authority||Biobank||Norway||Collection and storage of biological material - also recording COVID-19 biobank samples in LabWare. Oslo, Norway.|
|Stockholm Medical Biobank||Biobank||Sweden||Regional Biobank responsible for biobanking of all health care samples in the Stockholm region - they are at this moment prioritizing studies related to COVID-19.|
|Swedish Liquid Based Cytology Biobanks||Biobank||Sweden||Several Swedish hospitals and Universities are using LabWare for biobanking of Liquid Based Cytology samples, 7 sites in different cities: Stockholm, Gothenburg, Umeå, Örebro, Lund, Kalmar, Linköping.|
|Swedish Medical Product Agency||Testing||Sweden||The national authority is responsible for regulation and surveillance of the development, manufacturing, and sale of pharmaceuticals and other medicinal products in Sweden. During the COVID-19 outbreak, the agency works with regulatory authorities in the EU and the European Medicines Agency (EMA) to support the rapid development of treatments and vaccines as well as ensuring access to medicines. Uppsala, Sweden.|
|The Cancer Council Victoria||Testing||Australia||Biobank assisting in cancer research and prevention.|
|The Capital Region of Denmark, Department of Clinical Immunology||Biobank||Denmark||Department of Clinical Immunology, Patient Biobank, Tissue Typing Laboratory - A research team from the Department of Clinical Immunology has developed an antibody test that can tell whether patients have developed COVID-19 antibodies after being infected, and they have been setting up a COVID-19 Biobank for patients (Coronavirus samples) and three sites in Copenhagen area, Denmark.|
|The South African AIDS Vaccine Initiative (SAAVI)||Testing||South Africa|
|The Region of Southern Denmark, Department of Clinical Genetics||Testing||Denmark||The Clinical Genetic Department handles genetic counseling and laboratory work. Two sites (Odense and Vejle), Denmark.|
|Uppsala Biobank||Biobank||Sweden||Regional Biobank responsible for storing biobanking of all health care samples in the Uppsala region, and also collecting samples from Uppsala University - currently prioritizing studies related to COVID-19.|
|USDA||Testing||USA|| In January 2021, President Biden released the National Strategy for the COVID-19 Response and Pandemic Preparedness (PDF, 24 MB). The plan calls on all parts of the federal government to contribute resources, facilities, personnel, and expertise to contain the pandemic. The U.S. Department of Agriculture (USDA) is responding to the President’s call to action. In addition to personnel, USDA is offering its facilities, cold chain infrastructure, public health experts, disaster response specialists, scientists and researchers, and footprint in rural areas and tribal communities across the country. With a presence in more than 140 countries around the world, USDA is working alongside federal partners to contain the outbreak and message about the importance of vaccinations for pandemic recovery.
|Victorian Clinical Genetic Services||Testing||Australia||A wholly-owned subsidiary of the Murdoch Children's Research Institute (MCRI) with expertise in cytogenetics, molecular genetics, biochemical genetics, mitochondrial genetics, and tissue culture.|
|Victorian Clinical Genetic Services - Newborn Screening||Testing||Australia||A wholly-owned subsidiary of the Murdoch Children's Research Institute (MCRI) with expertise in newborn screening.|
|Victorian Department of Primary Industries||Testing||Australia||Government testing in agriculture, biosecurity, fisheries, earth resources, energy, and forestry policy and programs in the State of Victoria, Australia.|
|VIDO/InterVac - Vaccine and Infectious Disease Organization - International Vaccine Center||Vaccine||Canada||VIDO-InterVac on track to become ‘Canada’s center for pandemic research’
A major takeaway from the COVID-19 pandemic is that emerging diseases require rapid responses and Canada needs to be better prepared to respond to the next one, says University of Saskatchewan research center leader Dr. Volker Gerdts (DVM).
do we have to wait until disease breaks out and then develop vaccines?” said Gerdts, director, and CEO of USask’s Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac).
“Why cannot we predict what the next pathogen will look like so when disease breaks out, we have vaccines available? It sounds naïve and really dreaming but that’s where the field is going, and VIDO-InterVac will be part of this.”
The idea of having adaptable vaccine platform technologies is part of Gerdts’ vision for VIDO-InterVac as “Canada’s center for pandemic research.” VIDO-InterVac is already a global leader in efforts to combat COVID-19 and the first in Canada to isolate the virus, develop an animal model, and get a vaccine into animal testing.
|Agbar (Barcelona Water)||Testing||Spain|
|Aqualia (several towns)||Testing||Spain|
|Bay of Plenty Regional Council||Testing||New Zealand||Government water utility testing.|
|CABB (Bilbao Water)||Testing||Spain|
|CYII (Madrid Water)||Testing||Spain|
|Cairns Regional Council||Testing||Australia||Government water utility testing.|
|Cawthron Institute||Testing||New Zealand||Government testing in aquaculture research, marine and freshwater resource management, food safety and quality, algal technologies, biosecurity, and analytical testing.|
|Emasa (Malaga Water)||Testing||Spain|
|Emasesa (Seville Water)||Testing||Spain|
|Emuasa (Murcia Water)||Testing||Spain|
|KWR||Testing||Netherlands||Water research lab COVID-19 sewage research.|
|Seqwater||Testing||Australia||Government water utility testing.|
|South Australian Water - Australian Water Quality Center||Testing||Australia||Government water utility testing.|
|Stockholm Vatten och Avfall||Testing||Sweden|
|Sydney Water Corporation||Testing||Australia||Government water utility testing.|
|Tasmania Department of Primary Industries, Parks Water and Environment||Testing||Australia||Government laboratory responsible for supporting primary industry development, the protection of Tasmania's natural environment, effective land and water management, and the protection of Tasmania's relative disease and pest-free status.|
|WLN||Testing||Netherlands||Independent partner in research and advice for drinking, industrial, and wastewater.|
|Watercare Services Limited||Testing||New Zealand||Government water utility testing.|
LabWare has been actively working with public and private sector organizations worldwide to apply our considerable know-how and advanced technology to implement COVID-19 testing capability and other workflow and operational efficiency enhancements to increase laboratory testing capacity to meet unprecedented public health testing demands.
Our efforts include assisting in the efforts to expand the NHS COVID-19 testing operations in the U.K.; providing laboratory management software for a new COVID-19 laboratory in Sao Paulo, Brazil; assisting U.S. public health customers to implement new COVID-19 tests and communications protocols for reporting to the CDC; adding/expanding COVID-19 testing capabilities throughout our public health customer base in sub-Saharan Africa, and assisting Canadian public health customers with performance improvements to handle the surge of COVID-19 tests.
We are developing solutions that leverage LabWare's mobile technology to streamline the COVID-19 patient registration and sample collection process as part of field-based specimen collection and COVID-19 testing operations. These solutions are being deployed at our state public health lab customers.
LabWare set out to solve this problem by introducing a system that uses tablet devices tied into a mobile hotspot and runs our app to communicate with a cloud-based HIPAA compliant server running our LIMS. The system allows scheduling patient visits to testing locations, capturing the patient demographic information and responses to the many triage questions. In the field, when specimen samples are collected, we print labels with a barcode as well as the patient's name and date of birth.
This information is used by the DOH (Department of Health) labs to identify the sample and patient. All data we are collecting is transmitted in minutes to the DOH system, so when the samples arrive at the lab, they are scanned and ready to be tested. We initially piloted this system in Florida in early April. The plan was to gather information on the gaps needed to enhance the system to be ready for live use.
Much to our surprise, what we had done met the needs of the DOH. We planned on departing Florida, but they told us they want to go live with the system right away. So, we stayed in Florida, and they went live the next week. Florida DOH has now committed to purchasing 303 kits, enough to roll out to every county.
More recently, we began deploying the Portable Disease Surveillance Lab kits in Delaware. The kits will be used to monitor hotspots within the state.
Instituto Butantan supplies 90% of the antivenin and 65% of all vaccines to the Brazilian public health system. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, Instituto Butantan produces 100 million units. In particular, they manufacture 100% of the influenza vaccine doses used by the Ministry of Health. Currently, the most significant flu vaccine manufacturer in the Southern Hemisphere, Instituto Butantan, is already processing COVID-19 samples and will coordinate 38 Laboratories in the São Paulo area.
NIAID scientists and grantees are well-positioned to develop COVID-19 diagnostics, therapeutics and vaccines rapidly. These projects include conducting basic research to understand how the virus infects cells and causes disease, and what interventions can prevent and stop disease spread.
In fact, within two weeks of the discovery of COVID-19, NIAID researchers had determined how the virus enters cells. And within two months sites had begun Phase 1 trials of a treatment (remdesivir) and a vaccine (mRNA-1273).
LabWare has started a project with PT Genomik Solidaritas Indonesia (GSI), a group of clinical laboratories that are to be managed and funded by Indika Energy. A new laboratory within GSI has been developed to do COVID-19 PCR Testing for Indonesia. The laboratory when fully operational will perform up to 10,000 specimens per day. LabWare's Clinical Health Solution (CHS) is already installed and running on GSI's ExiPrep instruments.
Los Alamos National Laboratory’s HIV team is now deploying its expertise in genetic databases and bioinformatics against the novel coronavirus SARS-CoV-2 by developing a T-cell response vaccine approach, tracking the origin of the pathogen, and developing a robust bioinformatics pipeline.
hVIVO, part of Open Orphan plc, has become a pioneer in the worldwide fight against COVID-19 by developing human challenge studies to improve our understanding of vaccine efficacy. hVIVO is expanding its use of LabWare LIMS to scale up the sample throughput for these studies.
Learn more about hVIVO and their use of LabWare LIMS in the Scientific Computing World article, "Open Orphan to begin world's first Covid-19 human challenge model."